132 related articles for article (PubMed ID: 28215225)
1. Transcription Factors in Breast Cancer-Lessons From Recent Genomic Analyses and Therapeutic Implications.
Zacksenhaus E; Liu JC; Jiang Z; Yao Y; Xia L; Shrestha M; Ben-David Y
Adv Protein Chem Struct Biol; 2017; 107():223-273. PubMed ID: 28215225
[TBL] [Abstract][Full Text] [Related]
2. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
3. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
4. Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.
Campbell TM; Castro MA; Ponder BA; Meyer KB
PLoS One; 2016; 11(12):e0168770. PubMed ID: 27997592
[TBL] [Abstract][Full Text] [Related]
5. Super-enhancers and novel therapeutic targets in colorectal cancer.
Liu Q; Guo L; Lou Z; Xiang X; Shao J
Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
[TBL] [Abstract][Full Text] [Related]
6. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
8. Identification of transcription factor co-regulators that drive prostate cancer progression.
Siddappa M; Wani SA; Long MD; Leach DA; Mathé EA; Bevan CL; Campbell MJ
Sci Rep; 2020 Nov; 10(1):20332. PubMed ID: 33230156
[TBL] [Abstract][Full Text] [Related]
9. Modulation of oncogenic transcription factors by bioactive natural products in breast cancer.
Hasanpourghadi M; Pandurangan AK; Mustafa MR
Pharmacol Res; 2018 Feb; 128():376-388. PubMed ID: 28923544
[TBL] [Abstract][Full Text] [Related]
10. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.
Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805820
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.
Petrovic J; Zhou Y; Fasolino M; Goldman N; Schwartz GW; Mumbach MR; Nguyen SC; Rome KS; Sela Y; Zapataro Z; Blacklow SC; Kruhlak MJ; Shi J; Aster JC; Joyce EF; Little SC; Vahedi G; Pear WS; Faryabi RB
Mol Cell; 2019 Mar; 73(6):1174-1190.e12. PubMed ID: 30745086
[TBL] [Abstract][Full Text] [Related]
12. Role of chromatin and transcriptional co-regulators in mediating p63-genome interactions in keratinocytes.
Sethi I; Sinha S; Buck MJ
BMC Genomics; 2014 Nov; 15(1):1042. PubMed ID: 25433490
[TBL] [Abstract][Full Text] [Related]
13. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
14. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering M; Barker N; Harkes IC; van der Heyden M; Dijk NJ; Hollestelle A; Klijn JG; Clevers H; Schutte M
Cancer Res; 2001 Jan; 61(1):278-84. PubMed ID: 11196175
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor corepressors -- a role in human breast cancer?
Dobrzycka KM; Townson SM; Jiang S; Oesterreich S
Endocr Relat Cancer; 2003 Dec; 10(4):517-36. PubMed ID: 14713265
[TBL] [Abstract][Full Text] [Related]
16. Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.
Chen L; Huang M; Plummer J; Pan J; Jiang YY; Yang Q; Silva TC; Gull N; Chen S; Ding LW; An O; Yang H; Cheng Y; Said JW; Doan N; Dinjens WN; Waters KM; Tuli R; Gayther SA; Klempner SJ; Berman BP; Meltzer SJ; Lin DC; Koeffler HP
Gut; 2020 Apr; 69(4):630-640. PubMed ID: 31409603
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals.
Katoh Y; Katoh M
Int J Oncol; 2009 Jul; 35(1):187-92. PubMed ID: 19513567
[TBL] [Abstract][Full Text] [Related]
18. Oncogene-initiated aberrant signaling engenders the metastatic phenotype: synergistic transcription factor interactions are targets for cancer therapy.
Denhardt DT
Crit Rev Oncog; 1996; 7(3-4):261-91. PubMed ID: 9258606
[TBL] [Abstract][Full Text] [Related]
19. BC-TFdb: a database of transcription factor drivers in breast cancer.
Khan A; Khan T; Nasir SN; Ali SS; Suleman M; Rizwan M; Waseem M; Ali S; Zhao X; Wei DQ
Database (Oxford); 2021 Apr; 2021():. PubMed ID: 33882119
[TBL] [Abstract][Full Text] [Related]
20. Inferring coregulation of transcription factors and microRNAs in breast cancer.
Wu JH; Sun YJ; Hsieh PH; Shieh GS
Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
